The DOI matches its Crossref record; 254 of the 254 references it cites were found in a registry or an index.
BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance
Open accessAbstract
genes and the role of BRCA mutations in tumor initiation, regulation of cancer stemness, therapy resistance and tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Identification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway
Lieber, M. R. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.052308.093131 · Cited by 2,882
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., Fiocco, R., Foroni, C., Dimeco, F., & Vescovi, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1364 · Cited by 2,570
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012
Stimpfel, M., & Virant-Klun, I. (2016) · Journal of Cancer Stem Cell Research · doi:10.14343/jcscr.2016.4e1003 · Cited by 2,540
Tumour heterogeneity and cancer cell plasticity
Meacham, C. E., & Morrison, S. J. (2013) · Nature · doi:10.1038/nature12624 · Cited by 2,446
Evolution of the Cancer Stem Cell Model
Kreso, A., & Dick, J. E. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.02.006 · Cited by 2,224
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
Litton, J. K., Rugo, H. S., Ettl, J., Hurvitz, S. A., Gonçalves, A., Lee, K.-H., Fehrenbacher, L., Yerushalmi, R., Mina, L. A., Martin, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1802905 · Cited by 2,175
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802
Mechanism of Eukaryotic Homologous Recombination
San Filippo, J., Sung, P., & Klein, H. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061306.125255 · Cited by 1,681
The DNA damage response and cancer therapy
Lord, C. J., & Ashworth, A. (2012) · Nature · doi:10.1038/nature10760 · Cited by 1,649
Free radicals and antioxidants in human health: current status and future prospects.
Devasagayam, T. P. A., Tilak, J. C., Boloor, K. K., Sane, K. S., Ghaskadbi, S., & Lele, R. D. (2004) · PubMed · Cited by 1,575
Cancer Risks in BRCA2 Mutation Carriers
Breast Cancer Linkage Consortium, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,527
Ubiquitin: structures, functions, mechanisms
Pickart, C. M., & Eddins, M. J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.019 · Cited by 1,407
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Takebe, N., Miele, L., Harris, P. J., Jeong, W., Bando, H., Kahn, M., Yang, S. X., & Ivy, S. P. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.61 · Cited by 1,298
Schlacher, K., Christ, N., Siaud, N., Egashira, A., Wu, H., & Jasin, M. (2011) · Cell · doi:10.1016/j.cell.2011.03.041 · Cited by 1,255
Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation
Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., Ellis, N. A., Boyd, J., Borgen, P. I., Barakat, R. R., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020119 · Cited by 1,251
Brca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Chromosomal stability and the DNA double-stranded break connection
van Gent, D. C., Hoeijmakers, J. H. J., & Kanaar, R. (2001) · Nature Reviews Genetics · doi:10.1038/35056049 · Cited by 1,219
Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198
Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van ’t Veer, L., Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.188 · Cited by 1,171
Expanding global access to radiotherapy
Atun, R., Jaffray, D. A., Barton, M. B., Bray, F., Baumann, M., Vikram, B., Hanna, T. P., Knaul, F. M., Lievens, Y., Lui, T. Y. M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00222-3 · Cited by 1,112
Cancer Incidence in BRCA1 Mutation Carriers
Thompson, D. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.18.1358 · Cited by 1,096
Pennington, K. P., Walsh, T., Harrell, M. I., Lee, M. K., Pennil, C. C., Rendi, M. H., Thornton, A., Norquist, B. M., Casadei, S., Nord, A. S., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2287 · Cited by 1,051
Cortez, D., Wang, Y., Qin, J., & Elledge, S. J. (1999) · Science · doi:10.1126/science.286.5442.1162 · Cited by 1,020
Resistance to therapy caused by intragenic deletion in BRCA2
Edwards, S. L., Brough, R., Lord, C. J., Natrajan, R., Vatcheva, R., Levine, D. A., Boyd, J., Reis-Filho, J. S., & Ashworth, A. (2008) · Nature · doi:10.1038/nature06548 · Cited by 1,011
BRCA2 Is Required for Homology-Directed Repair of Chromosomal Breaks
Moynahan, M. E., Pierce, A. J., & Jasin, M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00174-5 · Cited by 1,006
Molecular views of recombination proteins and their control
West, S. C. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1127 · Cited by 956
MDC1 is a mediator of the mammalian DNA damage checkpoint
Stewart, G. S., Wang, B., Bignell, C. R., Taylor, A. M. R., & Elledge, S. J. (2003) · Nature · doi:10.1038/nature01446 · Cited by 874
Bapat, S. A., Mali, A. M., Koppikar, C. B., & Kurrey, N. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3931 · Cited by 760
Xu, X., Wagner, K.-U., Larson, D., Weaver, Z., Li, C., Ried, T., Hennighausen, L., Wynshaw-Boris, A., & Deng, C.-X. (1999) · Nature Genetics · doi:10.1038/8743 · Cited by 758
Biological Consequences of Radiation-induced DNA Damage: Relevance to Radiotherapy
Lomax, M. E., Folkes, L. K., & O'Neill, P. (2013) · Clinical Oncology · doi:10.1016/j.clon.2013.06.007 · Cited by 738
Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program
Brose, M. S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.18.1365 · Cited by 728
Role of BRCA2 in Control of the RAD51 Recombination and DNA Repair Protein
Davies, A. A., Masson, J.-Y., McIlwraith, M. J., Stasiak, A. Z., Stasiak, A., Venkitaraman, A. R., & West, S. C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00175-7 · Cited by 718
Heppner, G. H. (1984) · PubMed · Cited by 676
Comparison of nonhomologous end joining and homologous recombination in human cells
MAO, Z., BOZZELLA, M., SELUANOV, A., & GORBUNOVA, V (2008) · DNA Repair · doi:10.1016/j.dnarep.2008.06.018 · Cited by 671
BRCT Repeats As Phosphopeptide-Binding Modules Involved in Protein Targeting
Manke, I. A., Lowery, D. M., Nguyen, A., & Yaffe, M. B. (2003) · Science · doi:10.1126/science.1088877 · Cited by 651
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
Welcsh, P. L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.705 · Cited by 648 · cited 1×
“It is known that starting from puberty period breast epithelium begins to proliferate rapidly in response to estrogen, therefore tissue-specificity of the BRCA1-related carcinogenesis can be attributed to its estrogen dependence [150].”
BackgroundHomologous recombination and its regulation
Krejci, L., Altmannova, V., Spirek, M., & Zhao, X. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks270 · Cited by 641
Hashizume, R., Fukuda, M., Maeda, I., Nishikawa, H., Oyake, D., Yabuki, Y., Ogata, H., & Ohta, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000881200 · Cited by 634
PALB2 is an integral component of the BRCA complex required for homologous recombination repair
Sy, S. M. H., Huen, M. S. Y., & Chen, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811159106 · Cited by 614
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution
Deng, C.-X. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl010 · Cited by 584
PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
Zhang, F., Ma, J., Wu, J., Ye, L., Cai, H., Xia, B., & Yu, X. (2009) · Current Biology · doi:10.1016/j.cub.2009.02.018 · Cited by 562
Hematopoietic stem cells: concepts, definitions, and the new reality
Eaves, C. J. (2015) · Blood · doi:10.1182/blood-2014-12-570200 · Cited by 549
BRCA1 Is Associated with a Human SWI/SNF-Related Complex
Bochar, D. A., Wang, L., Beniya, H., Kinev, A., Xue, Y., Lane, W. S., Wang, W., Kashanchi, F., & Shiekhattar, R. (2000) · Cell · doi:10.1016/s0092-8674(00)00030-1 · Cited by 546
BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2
Bhatia, V., Barroso, S. I., García-Rubio, M. L., Tumini, E., Herrera-Moyano, E., & Aguilera, A. (2014) · Nature · doi:10.1038/nature13374 · Cited by 537
hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
Lee, J.-S., Collins, K. M., Brown, A. L., Lee, C.-H., & Chung, J. H. (2000) · Nature · doi:10.1038/35004614 · Cited by 529
Peñuelas, S., Anido, J., Prieto-Sánchez, R. M., Folch, G., Barba, I., Cuartas, I., García-Dorado, D., Poca, M. A., Sahuquillo, J., Baselga, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.011 · Cited by 526
Regulation of mammary stem/progenitor cells by PTEN/Akt/β-catenin signaling
Korkaya, H., Paulson, A., Charafe-Jauffret, E., Ginestier, C., Brown, M., Dutcher, J., Clouthier, S. G., & Wicha, M. S. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000121 · Cited by 523
Byrski, T., Gronwald, J., Huzarski, T., Grzybowska, E., Budryk, M., Stawicka, M., Mierzwa, T., Szwiec, M., Wiśniowski, R., Siolek, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7019 · Cited by 516
Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress
Tibbetts, R. S., Cortez, D., Brumbaugh, K. M., Scully, R., Livingston, D., Elledge, S. J., & Abraham, R. T. (2000) · Genes & Development · doi:10.1101/gad.851000 · Cited by 512
Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian
Mersch, J., Jackson, M. A., Park, M., Nebgen, D., Peterson, S. K., Singletary, C., Arun, B. K., & Litton, J. K. (2015) · Cancer · doi:10.1002/cncr.29041 · Cited by 511
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl
Somasundaram, K., Zhang, H., Zeng, Y.-X., Houvras, Y., Peng, Y., Zhang, H., Wu, G. S., Licht, J. D., Weber, B. L., & El-Deiry, W. S. (1997) · Nature · doi:10.1038/38291 · Cited by 509
Gayther, S. A., Warren, W., Mazoyer, S., Russell, P. A., Harrington, P. A., Chiano, M., Seal, S., Hamoudi, R., van Rensburg, E. J., Dunning, A. M., et al. (1995) · Nature Genetics · doi:10.1038/ng1295-428 · Cited by 496
Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death
Herceg, Z., & Wang, Z.-Q. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00111-7 · Cited by 488
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
Fackenthal, J. D., & Olopade, O. I. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2054 · Cited by 488
BRCA1 tumour suppression occurs via heterochromatin-mediated silencing
Zhu, Q., Pao, G. M., Huynh, A. M., Suh, H., Tonnu, N., Nederlof, P. M., Gage, F. H., & Verma, I. M. (2011) · Nature · doi:10.1038/nature10371 · Cited by 485
BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage
Yarden, R. I., Pardo-Reoyo, S., Sgagias, M., Cowan, K. H., & Brody, L. C. (2002) · Nature Genetics · doi:10.1038/ng837 · Cited by 484
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study
Copson, E. R., Maishman, T. C., Tapper, W. J., Cutress, R. I., Greville-Heygate, S., Altman, D. G., Eccles, B., Gerty, S., Durcan, L. T., Jones, L., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30891-4 · Cited by 481
Ellisen, L. W., Ramsayer, K. D., Johannessen, C. M., Yang, A., Beppu, H., Minda, K., Oliner, J. D., McKeon, F., & Haber, D. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00706-2 · Cited by 474
BRCA1 regulates human mammary stem/progenitor cell fate
Liu, S., Ginestier, C., Charafe-Jauffret, E., Foco, H., Kleer, C. G., Merajver, S. D., Dontu, G., & Wicha, M. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711613105 · Cited by 461
Goto, H., Kosako, H., Tomono, Y., Ajiro, K., Fujita, M., Sakurai, M., Okawa, K., Iwamatsu, A., Okigaki, T., Takahashi, T., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25543 · Cited by 457
Evidence for a transcriptional activation function of BRCA1 C-terminal region
Monteiro, A. N. A., August, A., & Hanafusa, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13595 · Cited by 446
Cancer stem cells and chemoresistance: The smartest survives the raid
Zhao, J. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.02.008 · Cited by 437
Isakoff, S. J., Mayer, E. L., He, L., Traina, T. A., Carey, L. A., Krag, K. J., Rugo, H. S., Liu, M. C., Stearns, V., Come, S. E., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.6660 · Cited by 436
The Role of BRCA1 in the Cellular Response to Chemotherapy
Kennedy, R. D., Quinn, J. E., Mullan, P. B., Johnston, P. G., & Harkin, D. P. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh312 · Cited by 430
Chen, L., Nievera, C. J., Lee, A. Y.-L., & Wu, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710245200 · Cited by 424
Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations of BRCA1
Rubin, S. C., Benjamin, I., Behbakht, K., Takahashi, H., Morgan, M. A., LiVolsi, V. A., Berchuck, A., Muto, M. G., Garber, J. E., Weber, B. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611073351901 · Cited by 423
Cancer risks in BRCA2 families: estimates for sites other than breast and ovary
van Asperen, C. J., Brohet, R. M., Meijers-Heijboer, E. J., Hoogerbrugge, N., Verhoef, S., Vasen, H. F. A., Ausems, M. G. E. M., Menko, F. H., Gomez Garcia, E. B., Klijn, J. G. M., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.028829 · Cited by 420
BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.
Yuan, S. F., Lee, S. Y., Chen, G., Song, M., Tomlinson, G. E., & Lee, E. Y.-H. P. (1999) · PubMed · Cited by 404
A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
Cojoc, M., Mäbert, K., Muders, M. H., & Dubrovska, A. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.06.004 · Cited by 393
Self-citationBRCA1 regulates p53-dependent gene expression
Ouchi, T., Monteiro, A. N. A., August, A., Aaronson, S. A., & Hanafusa, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2302 · Cited by 375
Cancer stem cells: The root of tumor recurrence and metastases
Peitzsch, C., Tyutyunnykova, A., Pantel, K., & Dubrovska, A. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.02.011 · Cited by 372
Self-citationMammalian Sirt1: insights on its biological functions
Rahman, S., & Islam, R. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-11 · Cited by 362
Ruffner, H., Joazeiro, C. A. P., Hemmati, D., Hunter, T., & Verma, I. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081068398 · Cited by 359
Identification of Tumor-Initiating Cells in a p53-Null Mouse Model of Breast Cancer
Zhang, M., Behbod, F., Atkinson, R. L., Landis, M. D., Kittrell, F., Edwards, D., Medina, D., Tsimelzon, A., Hilsenbeck, S., Green, J. E., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6353 · Cited by 352
The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA–ssDNA junction
Yang, H., Li, Q., Fan, J., Holloman, W. K., & Pavletich, N. P. (2005) · Nature · doi:10.1038/nature03234 · Cited by 336
Prevention of Brca1 -Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist
Poole, A. J., Li, Y., Kim, Y., Lin, S.-C. J., Lee, W.-H., & Lee, E. Y.-H. P. (2006) · Science · doi:10.1126/science.1130471 · Cited by 332
Ovarian Cancer: Etiology, Risk Factors, and Epidemiology
HUNN, J., & RODRIGUEZ, G. C. (2012) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31824b4611 · Cited by 324
Chk2 Phosphorylation of BRCA1 Regulates DNA Double-Strand Break Repair
Zhang, J., Willers, H., Feng, Z., Ghosh, J. C., Kim, S., Weaver, D. T., Chung, J. H., Powell, S. N., & Xia, F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.708-718.2004 · Cited by 323
Sakai, W., Swisher, E. M., Jacquemont, C., Chandramohan, K. V., Couch, F. J., Langdon, S. P., Wurz, K., Higgins, J., Villegas, E., & Taniguchi, T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1178 · Cited by 321
How many more breast cancer predisposition genes are there?
Easton, D. F. (1999) · Breast Cancer Research · doi:10.1186/bcr6 · Cited by 315
PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2
Zhang, F., Fan, Q., Ren, K., & Andreassen, P. R. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0123 · Cited by 306
BRCA1-Dependent Ubiquitination of γ-Tubulin Regulates Centrosome Number
Starita, L. M., Machida, Y., Sankaran, S., Elias, J. E., Griffin, K., Schlegel, B. P., Gygi, S. P., & Parvin, J. D. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8457-8466.2004 · Cited by 302
Estrogen Receptor Status in BRCA1 - and BRCA2 -Related Breast Cancer
Foulkes, W. D., Metcalfe, K., Sun, P., Hanna, W. M., Lynch, H. T., Ghadirian, P., Tung, N., Olopade, O. I., Weber, B. L., McLennan, J., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-1061 · Cited by 293
Human BRCA1–BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection
Densham, R. M., Garvin, A. J., Stone, H. R., Strachan, J., Baldock, R. A., Daza-Martin, M., Fletcher, A., Blair-Reid, S., Beesley, J., Johal, B., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3236 · Cited by 290
BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival
Gorrini, C., Baniasadi, P. S., Harris, I. S., Silvester, J., Inoue, S., Snow, B., Joshi, P. A., Wakeham, A., Molyneux, S. D., Martin, B., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121337 · Cited by 289
Cancer Suppression by the Chromosome Custodians, BRCA1 and BRCA2
Venkitaraman, A. R. (2014) · Science · doi:10.1126/science.1252230 · Cited by 289
BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP
Yu, X., Fu, S., Lai, M., Baer, R., & Chen, J. (2006) · Genes & Development · doi:10.1101/gad.1431006 · Cited by 284
Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains
Mallery, D. L. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf691 · Cited by 282
Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.
Heppner, G. H., Dexter, D. L., DeNucci, T., Miller, F. R., & Calabresi, P. A. (1978) · PubMed · Cited by 280
Ubiquitination: Friend and foe in cancer
Mansour, M. A. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.06.001 · Cited by 273
The BRCA 2 gene product functionally interacts with p53 and RAD51
Marmorstein, L. Y., Ouchi, T., & Aaronson, S. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13869 · Cited by 267
Fanconi's anemia and malignancies
Alter, B. P. (1996) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199610)53:2<99::aid-ajh7>3.0.co;2-z · Cited by 267
Role of direct interaction in BRCA1 inhibition of estrogen receptor activity
Fan, S., Ma, Y. X., Wang, C., Yuan, R.-Q., Meng, Q., Wang, J.-A., Erdos, M., Goldberg, I. D., Webb, P., Kushner, P. J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204073 · Cited by 263
The Genetic Epidemiology of Breast Cancer Genes
Thompson, D., & Easton, D. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000048770.90334.3b · Cited by 257
BRCA1 transcriptionally regulates genes involved in breast tumorigenesis
Welcsh, P. L., Lee, M. K., Gonzalez-Hernandez, R. M., Black, D. J., Mahadevappa, M., Swisher, E. M., Warrington, J. A., & King, M.-C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062181799 · Cited by 256
Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations
Rycaj, K., & Tang, D. G. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0798 · Cited by 256
Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein
Lomonosov, M., Anand, S., Sangrithi, M., Davies, R., & Venkitaraman, A. R. (2003) · Genes & Development · doi:10.1101/gad.279003 · Cited by 256
Bancroft, E. K., Page, E. C., Castro, E., Lilja, H., Vickers, A., Sjoberg, D., Assel, M., Foster, C. S., Mitchell, G., Drew, K., et al. (2014) · European Urology · doi:10.1016/j.eururo.2014.01.003 · Cited by 254
Fanconi Anemia Proteins Function in Mitophagy and Immunity
Sumpter, R., Sirasanagandla, S., Fernández, Á. F., Wei, Y., Dong, X., Franco, L., Zou, Z., Marchal, C., Lee, M. Y., Clapp, D. W., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.006 · Cited by 250 · cited 2×
“Knockdown of BRCA1 and BRCA2 inhibited the clearance of mitochondria by mitophagy after treatment with oligomycin and antimycin A (two specific inhibitors of mitochondrial respiration) or with PARP inhibitor AZD2281 [122]– [124].”
MethodBRCA1 and BRCA2 mutations and treatment strategies for breast cancer
Godet, I., & M. Gilkes, D. (2017) · Integrative Cancer Science and Therapeutics · doi:10.15761/icst.1000228 · Cited by 250
Latifi, A., Luwor, R. B., Bilandzic, M., Nazaretian, S., Stenvers, K., Pyman, J., Zhu, H., Thompson, E. W., Quinn, M. A., Findlay, J. K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046858 · Cited by 240
DNA Repair in Prostate Cancer: Biology and Clinical Implications
Mateo, J., Boysen, G., Barbieri, C. E., Bryant, H. E., Castro, E., Nelson, P. S., Olmos, D., Pritchard, C. C., Rubin, M. A., & de Bono, J. S. (2017) · European Urology · doi:10.1016/j.eururo.2016.08.037 · Cited by 239
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories
Taylor, R. A., Fraser, M., Livingstone, J., Espiritu, S. M. G., Thorne, H., Huang, V., Lo, W., Shiah, Y.-J., Yamaguchi, T. N., Sliwinski, A., et al. (2017) · Nature Communications · doi:10.1038/ncomms13671 · Cited by 234
Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155
Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Chang, S., Wang, R.-H., Akagi, K., Kim, K.-A., Martin, B. K., Cavallone, L., Haines, D. C., Basik, M., Mai, P., et al. (2011) · Nature Medicine · doi:10.1038/nm.2459 · Cited by 224
Autoubiquitination of the BRCA1·BARD1 RING Ubiquitin Ligase
Chen, A., Kleiman, F. E., Manley, J. L., Ouchi, T., & Pan, Z.-Q. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201252200 · Cited by 217
Konecny, G. E., & Kristeleit, R. S. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.311 · Cited by 216
STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1
Clark, S. L., Rodriguez, A. M., Snyder, R. R., Hankins, G. D. V., & Boehning, D. (2012) · Computational and Structural Biotechnology Journal · doi:10.5936/csbj.201204005 · Cited by 214
BRCA1 Effects on the Cell Cycle and the DNA Damage Response Are Linked to Altered Gene Expression
MacLachlan, T. K., Somasundaram, K., Sgagias, M., Shifman, Y., Muschel, R. J., Cowan, K. H., & El-Deiry, W. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2777 · Cited by 212
Vencken, P. M. L. H., Kriege, M., Hoogwerf, D., Beugelink, S., van der Burg, M. E. L., Hooning, M. J., Berns, E. M., Jager, A., Collée, M., Burger, C. W., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq628 · Cited by 212
BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor
Zheng, L., Annab, L. A., Afshari, C. A., Lee, W.-H., & Boyer, T. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171174298 · Cited by 212
Byrski, T., Dent, R., Blecharz, P., Foszczynska-Kloda, M., Gronwald, J., Huzarski, T., Cybulski, C., Marczyk, E., Chrzan, R., Eisen, A., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3231 · Cited by 210
Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways
Hussain, S. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh135 · Cited by 208
Ye, Q., Hu, Y.-F., Zhong, H., Nye, A. C., Belmont, A. S., & Li, R. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200108049 · Cited by 206
Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment
Hanna, A., & Shevde, L. A. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0509-3 · Cited by 205
Ouchi, T., Lee, S. W., Ouchi, M., Aaronson, S. A., & Horvath, C. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080469697 · Cited by 201
Application of Breast Cancer Risk Prediction Models in Clinical Practice
Domchek, S. M., Eisen, A., Calzone, K., Stopfer, J., Blackwood, A., & Weber, B. L. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.007 · Cited by 201
Triple Negative Breast Cancer – An Overview
Akshata Desai, K. A. (2012) · Hereditary Genetics · doi:10.4172/2161-1041.s2-001 · Cited by 200
BRCA1 is a cell cycle-regulated nuclear phosphoprotein
Ruffner, H., & Verma, I. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7138 · Cited by 196
Qiao, S., Dennis, M., Song, X., Vadysirisack, D. D., Salunke, D., Nash, Z., Yang, Z., Liesa, M., Yoshioka, J., Matsuzawa, S.-I., et al. (2015) · Nature Communications · doi:10.1038/ncomms8014 · Cited by 195
Molecular Basis for Estrogen Receptor Deficiency in BRCA1-Linked Breast Cancer
Hosey, A. M., Gorski, J. J., Murray, M. M., Quinn, J. E., Chung, W. Y., Stewart, G. E., James, C. R., Farragher, S. M., Mulligan, J. M., Scott, A. N., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm207 · Cited by 194
Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase
Eakin, C. M., MacCoss, M. J., Finney, G. L., & Klevit, R. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610887104 · Cited by 192
PARP inhibitors: review of mechanisms of action and BRCA1/2 mutation targeting
Dziadkowiec, K. N., Gąsiorowska, E., Nowak-Markwitz, E., & Jankowska, A. (2016) · Menopausal Review · doi:10.5114/pm.2016.65667 · Cited by 191
Discovery of the cancer stem cell related determinants of radioresistance
Peitzsch, C., Kurth, I., Kunz-Schughart, L., Baumann, M., & Dubrovska, A. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.003 · Cited by 189
Self-citationVariation in BRCA1 cancer risks by mutation position.
Thompson, D. J., & Easton, D. F. (2002) · PubMed · Cited by 187
BRCA1 Directs the Repair Pathway to Homologous Recombination by Promoting 53BP1 Dephosphorylation
Isono, M., Niimi, A., Oike, T., Hagiwara, Y., Sato, H., Sekine, R., Yoshida, Y., Isobe, S.-Y., Obuse, C., Nishi, R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.042 · Cited by 178
Promotion of BRCA2-Dependent Homologous Recombination by DSS1 via RPA Targeting and DNA Mimicry
Zhao, W., Vaithiyalingam, S., San Filippo, J., Maranon, D. G., Jimenez-Sainz, J., Fontenay, G. V., Kwon, Y., Leung, S. G., Lu, L., Jensen, R. B., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.032 · Cited by 177
A Comprehensive Focus on Global Spectrum of BRCA1 and BRCA2 Mutations in Breast Cancer
Karami, F., & Mehdipour, P. (2013) · BioMed Research International · doi:10.1155/2013/928562 · Cited by 173
Arun, B., Bayraktar, S., Liu, D. D., Gutierrez Barrera, A. M., Atchley, D., Pusztai, L., Litton, J. K., Valero, V., Meric-Bernstam, F., Hortobagyi, G. N., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.2682 · Cited by 172
The role of BRCA1 and BRCA2 in prostate cancer
Castro, E., & Eeles, R. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2011.150 · Cited by 170
Alternative end-joining pathway(s): Bricolage at DNA breaks
Frit, P., Barboule, N., Yuan, Y., Gomez, D., & Calsou, P. (2014) · DNA Repair · doi:10.1016/j.dnarep.2014.02.007 · Cited by 167
The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers
Cavanagh, H., & Rogers, K. (2015) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-015-0038-x · Cited by 163
A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint
Wang, R.-H., Yu, H., & Deng, C.-X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407585101 · Cited by 163
BRCA2 acts as a RAD51 loader to facilitate telomere replication and capping
Badie, S., Escandell, J. M., Bouwman, P., Carlos, A. R., Thanasoula, M., Gallardo, M. M., Suram, A., Jaco, I., Benitez, J., Herbig, U., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1943 · Cited by 162
RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer
Liu, Y., Burness, M. L., Martin-Trevino, R., Guy, J., Bai, S., Harouaka, R., Brooks, M. D., Shang, L., Fox, A., Luther, T. K., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1348 · Cited by 162
Mechanisms of BRCA1 Tumor Suppression
Silver, D. P., & Livingston, D. M. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0221 · Cited by 159
Holliday junction resolution: Regulation in space and time
Matos, J., & West, S. C. (2014) · DNA Repair · doi:10.1016/j.dnarep.2014.03.013 · Cited by 158
BRCA1-associated growth arrest is RB-dependent
Aprelikova, O. N., Fang, B. S., Meissner, E. G., Cotter, S., Campbell, M., Kuthiala, A., Bessho, M., Jensen, R. A., & Liu, E. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11866 · Cited by 158
Meng, E., Mitra, A., Tripathi, K. K., Finan, M. A., Scalici, J. M., McClellan, S., da Silva, L. M., Reed, E., Shevde, L. A., Palle, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107142 · Cited by 157
Nucleophosmin/B23 Is a Candidate Substrate for the BRCA1-BARD1 Ubiquitin Ligase
Sato, K., Hayami, R., Wu, W., Nishikawa, T., Nishikawa, H., Okuda, Y., Ogata, H., Fukuda, M., & Ohta, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400169200 · Cited by 156
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents
Mullan, P. B., Quinn, J. E., Gilmore, P. M., McWilliams, S., Andrews, H. N., Gervin, C., McCabe, N., McKenna, S., White, P., Song, Y., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204712 · Cited by 154
HERC2 Is an E3 Ligase That Targets BRCA1 for Degradation
Wu, W., Sato, K., Koike, A., Nishikawa, H., Koizumi, H., Venkitaraman, A. R., & Ohta, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1304 · Cited by 150
Marmorstein, L. Y., Kinev, A. V., Chan, G. K. T., Bochar, D. A., Beniya, H., Epstein, J. A., Yen, T. J., & Shiekhattar, R. (2001) · Cell · doi:10.1016/s0092-8674(01)00209-4 · Cited by 147
Pharoah, P., Easton, D. F., Stockton, D., Gayther, S. A., & Ponder, B. A. J. (1999) · PubMed · Cited by 139
Kawai, H., Li, H., Chun, P., Avraham, S., & Avraham, H. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205971 · Cited by 137
Ison, G., Howie, L. J., Amiri‐Kordestani, L., Zhang, L., Tang, S. W., Sridhara, R., Pierre, V., Charlab, R., Ramamoorthy, A., Song, P., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0042 · Cited by 137
On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations
Hamel, N., Feng, B., Foretová, L., Stoppa‐Lyonnet, D., Narod, S. A., Имянитов, Е. Н., Sinilnikova, O. M., Tihomirova, L., Lubiński, J., Gronwald, J., et al. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.203 · Cited by 135
Ueki, T., Park, J.-H., Nishidate, T., Kijima, K., Hirata, K., Nakamura, Y., & Katagiri, T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1809 · Cited by 133
Lim, J. Y., Yang, K. Y., Taylor‐Harding, B., Wiedemeyer, W. R., & Buckanovich, R. J. (2014) · Neoplasia · doi:10.1016/j.neo.2014.04.003 · Cited by 131
The sex hormone system in carriers of BRCA1/2 mutations: a case-control study
Widschwendter, M., Rosenthal, A. N., Philpott, S., Rizzuto, I., Fraser, L. S. M., Hayward, J. D., Intermaggio, M. P., Edlund, C. K., Ramus, S. J., Gayther, S. A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70448-0 · Cited by 130
Estrogen controls the survival of BRCA1-deficient cells via a PI3K–NRF2-regulated pathway
Gorrini, C., Gang, B. P., Bassi, C., Wakeham, A. C., Baniasadi, S. P., Hao, Z., Li, W. Y., Cescon, D. W., Li, Y.-T., Molyneux, S. D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324136111 · Cited by 127
Choudhury, A. D., Xu, H., & Baer, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403646200 · Cited by 126
Ma, Y.-X., Katiyar, P., Jones, L., Fan, S., Zhang, Y.-Y., Furth, P., & Rosen, E. (2006) · Molecular Endocrinology · doi:10.1210/me.2004-0488 · Cited by 125
Mateo, J., Cheng, H. H., Beltran, H., Dolling, D. I., Xu, W., Pritchard, C. C., Mossop, H., Rescigno, P., Pérez-López, R., Sailer, V., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.01.010 · Cited by 124
Update on PARP Inhibitors in Breast Cancer
Zimmer, A. S., Gillard, M., Lipkowitz, S., & Lee, J. (2018) · Current Treatment Options in Oncology · doi:10.1007/s11864-018-0540-2 · Cited by 124
Germline breast cancer susceptibility gene mutations and breast cancer outcomes
Wang, Y. A., Jian, J.-W., Hung, C., Peng, H., Yang, C., Cheng, S. H., & Yang, A. (2018) · BMC Cancer · doi:10.1186/s12885-018-4229-5 · Cited by 124
Concise Review: Prostate Cancer Stem Cells: Current Understanding
Skvortsov, S., Skvortsova, I., Tang, D. G., & Dubrovska, A. (2018) · Stem Cells · doi:10.1002/stem.2859 · Cited by 124
Self-citationDesai, A. B., Webb, B. M., & Gerson, S. L. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.10.040 · Cited by 122
Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing.
Humphrey, J. S., Salim, A., Erdos, M., Collins, F., Brody, L. C., & Klausner, R. (1997) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.94.11.5820 · Cited by 120
Arun, B., Akar, U., Gutierrez‐Barrera, A. M., Hortobágyi, G. N., & Özpolat, B. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3003 · Cited by 119
Constitutive activation of JAK–STAT3 signaling by BRCA1 in human prostate cancer cells
Gao, B., Shen, X., Kunos, G., Meng, Q., Goldberg, I. D., Rosen, E. M., & Fan, S. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02430-3 · Cited by 119
Zhuang, J., Zhang, J., Willers, H., Wang, H., Chung, J. H., van Gent, D. C., Hallahan, D. E., Powell, S. N., & Xia, F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3278 · Cited by 119
Involvement of oxidatively damaged DNA and repair in cancer development and aging.
Tudek, B., Winczura, A., Janik, J., Siomek, A., Foksiński, M., & Oliński, R. (2010) · PubMed · Cited by 114
The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans
Moynahan, M. E. (2002) · Oncogene · doi:10.1038/sj.onc.1206177 · Cited by 114
BRCA1 is a negative modulator of the PRC2 complex
Wang, L., Zeng, X., Chen, S., Ding, L., Zhong, J., Zhao, J. C., Wang, L., Sarver, A. L., Koller, A. A., Zhi, J., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.95 · Cited by 111
Razandi, M., Pedram, A., Rosen, E. M., & Levin, E. R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5900-5913.2004 · Cited by 108
Kriege, M., Jager, A., Hooning, M. J., Huijskens, E., Blom, J., van Deurzen, C. H. M., Bontenbal, M., Collée, J. M., Menke‐Pluijmers, M. B. E., Martens, J. W. M., et al. (2011) · Cancer · doi:10.1002/cncr.26351 · Cited by 96
Deciphering the BRCA1 Tumor Suppressor Network
Jiang, Q., & Greenberg, R. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.667931 · Cited by 96
Mote, P. A., Leary, J. A., Avery‐Kiejda, K. A., Sandelin, K., Chenevix‐Trench, G., Kirk, J., & Clarke, C. L. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10321 · Cited by 96
Jeffy, B. D., Hockings, J. K., Kemp, M. Q., Morgan, S. S., Hager, J. A., Beliakoff, J., Whitesell, L. J., Bowden, G. T., & Romagnolo, D. F. (2005) · Neoplasia · doi:10.1593/neo.05256 · Cited by 95
Chen, J. (2000) · PubMed · Cited by 94
BRCA2 functions: from DNA repair to replication fork stabilization
Fradet‐Turcotte, A., Sitz, J., Grapton, D., & Orthwein, A. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0297 · Cited by 91
Martinez‐Outschoorn, U., Balliet, R. M., Lin, Z., Whitaker‐Menezes, D., Birbe, R., Bombonati, A., Pavlides, S., Lamb, R., Sneddon, S., Howell, A., et al. (2012) · Cell Cycle · doi:10.4161/cc.22776 · Cited by 90
Gyanchandani, R., Lin, Y., Lin, H., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2889 · Cited by 88
Risk-Reducing Salpingo-Oophorectomy in Women With a BRCA1 or BRCA2 Mutation
Kauff, N. D., Satagopan, J. M., Robson, M. E., et al. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200209000-00016 · Cited by 86
BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer
Gorski, J. J., James, C. R., Quinn, J. E., Stewart, G. E., Crosbie-Staunton, K., Buckley, N. E., McDyer, F. A., Kennedy, R. D., Wilson, R. H., Mullan, P. B., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0565-0 · Cited by 84
Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis
Jiang, T., Shi, W., Wali, V. B., Pongor, L. S., Li, C., Lau, R., Győrffy, B., Lifton, R. P., Symmans, W. F., Pusztai, L., et al. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002193 · Cited by 84
Alternative pathways of non-homologous end joining (NHEJ) in genomic instability and cancer
Dueva, R., & Iliakis, G. E. (2013) · Translational Cancer Research · doi:10.21037/1152 · Cited by 83
BRCA1 down‐regulates cellular levels of reactive oxygen species
Saha, T., Rih, J. K., & Rosen, E. M. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.04.005 · Cited by 79
Increased Expression of DNA Repair Genes in Invasive Human Pancreatic Cancer Cells
Mathews, L., Cabarcas‐Petroski, S., Hurt, E. M., Zhang, X., Jaffee, E. M., & Farrar, W. L. (2011) · Pancreas · doi:10.1097/mpa.0b013e31821ae25b · Cited by 77
Afghahi, A., Timms, K. M., Vinayak, S., Jensen, K. C., Kurian, A. W., Carlson, R. W., Chang, P.-J., Schackmann, E. A., Hartman, A., Ford, J. M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2174 · Cited by 77
Liu, X., Chen, X., Rycaj, K., Chao, H., Deng, Q., Jeter, C. R., Liu, C., Honorio, S., Li, H., Davis, T., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4260 · Cited by 76
BRCA1 targets G2/M cell cycle proteins for ubiquitination and proteasomal degradation
Shabbeer, S., Omer, D., Berneman, D., Weitzman, O., Alpaugh, A., Pietraszkiewicz, A. A., Metsuyanim, S., Shainskaya, A., Papa, M. Z., & Yarden, R. I. (2012) · Oncogene · doi:10.1038/onc.2012.522 · Cited by 72
TGFβ1/Smad3 counteracts BRCA1-dependent repair of DNA damage
Dubrovska, A., Kanamoto, T., Lomnytska, M. I., Heldin, C., Volodko, N., & Souchelnytskyi, S. (2005) · Oncogene · doi:10.1038/sj.onc.1208443 · Cited by 67
Self-citationThe F-box Protein FBXO44 Mediates BRCA1 Ubiquitination and Degradation
Lu, Y., Li, J., Cheng, D., Parameswaran, B., Zhang, S., Jiang, Z., Yew, P. R., Peng, J., Ye, Q., & Hu, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.407106 · Cited by 67
Walsh, T., Mandell, J. B., Norquist, B. M., Casadei, S., Gülsüner, S., Lee, M. K., & King, M. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.1996 · Cited by 66
Distinct binding of BRCA2 BRC repeats to RAD51 generates differential DNA damage sensitivity
Chatterjee, G., Jiménez-Sáinz, J., Presti, T., Nguyen, T. T. M., & Jensen, R. B. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw242 · Cited by 65
BRCA1 DNA-Binding Activity Is Stimulated by BARD1
Simons, A. M., Horwitz, A. A., Starita, L. M., Griffin, K., Williams, R. S., Glover, J. N. M., & Parvin, J. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3296 · Cited by 64
Cited by
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Huang, R.-X., & Zhou, P.-K. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0150-x · Cited by 1,198
The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication
Tarsounas, M., & Sung, P. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0218-z · Cited by 359
Piombino, C., Pipitone, S., Tonni, E., Mastrodomenico, L., Oltrecolli, M., Tchawa, C., Matranga, R., Roccabruna, S., D’Agostino, E., Pirola, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094624 · Cited by 15
Metadata
- Authors
- Gorodetska, I., Kozeretska, I., & Dubrovska, A.
- Venue
- Journal of Cancer
- Publisher
- Ivyspring International Publisher
- Published
- 2019
- Volume
- 10
- Issue
- 9
- Pages
- 2109-2127
- ISSN
- 1837-9664 (ISSN-L)
- OpenAlex
- W2947754660
- Cited by
- 269
- References
- 254
- FWCI
- 14.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.